BPA Call 36C25724A0020-36C25726N0313
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded Mdxhealth, Inc. a $27,657.57 firm fixed-price blanket purchase agreement call for DX Prostate Testing services. The award, issued on April 3, 2025, with an ultimate completion date of April 2, 2026, represents a delivery order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Mdxhealth, a for-profit molecular diagnostic company headquartered in Irvine,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17) awarded Mdxhealth, Inc. a $15,964.65 firm fixed price contract call under an existing Blanket Purchase Agreement for Genomic Prostate Score (GPS) testing services. This contract call, with an ultimate completion date of June 4, 2027, represents a delivery order against Mdxhealth's $240,000 BPA for MDXHEALTH GPS services established on May 1, 2023 and extending through June 4, 2028. The contract is issued under...
- This is a $9,696.96 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract is for DX Prostate Testing services, which will be delivered to the Veterans Integrated Service Network (VISN) 17 over a period ending on January 9, 2027. The contract was awarded on January 10, 2026 and is not set aside....
- Mdxhealth, Inc. was awarded a $9,578.79 firm fixed price call under a Blanket Purchase Agreement with Veterans Integrated Service Network 17 (VISN 17) on April 3, 2024, for AMA Oncotype Prostate Cancer Testing services. The work will be performed at Mdxhealth's facility in Irvine, California, with an ultimate completion date of April 2, 2025. This call order falls under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), a General Services Administration...
- Mdxhealth, Inc. received a $15,964.65 firm fixed price contract award from the Department of Veterans Affairs' Veterans Integrated Service Network 17 on June 5, 2025. This BPA call is for Genomic Prostate Score (GPS) testing services, a molecular diagnostic test designed to assess prostate cancer risk and guide personalized treatment decisions for veterans. The contract carries no set-aside designation and represents a delivery order against Mdxhealth's existing $240,000 blanket purchase...
- This federal contract award to Mdxhealth, Inc. is for the provision of Oncotype DX Prostate Testing services to the Veterans Integrated Service Network (VISN) 17, which is part of the U.S. Department of Veterans Affairs (VA). The $319,293.00 Blanket Purchase Agreement (BPA) call contract is made under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and has a period of performance through April 30, 2026. Mdxhealth, a for-profit healthcare company...
- This is a $85,939.20 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company based in Irvine, California. The contract is for the provision of prostate cancer testing services under Option Three of the "PROSTATE CANCER TEST" program, with a performance period through June 30, 2026. The contract is not designated as a set-aside. This BPA call is part of a larger indefinite...
- This is a federal contract award by the Veterans Integrated Service Network 8 (VISN 8), which is part of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract, valued at $144,666.36, is a Blanket Purchase Agreement (BPA) call for providing prostate cancer testing services to the VA. This contract is not set aside and is issued under the Medical Laboratory...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to MDXHealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract, valued at $114,920.07, is for MDX health testing services to support the VA's healthcare delivery to veterans within VISN 19. This contract is part of a larger Medical Laboratory...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 17 (VISN 17), a regional network within the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. The contract is for the provision of Oncotype DX genomic prostate cancer testing services to the Big Spring VA Medical Center. The award, which has a firm fixed price and a ceiling value of $9,696.96, is made under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- V797D70066-36C25724A0020Blanket Purchase Agreement
- 36C25724A0020-36C25726N0313BPA Call
The Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded a $27,657.57 firm fixed-price Blanket Purchase Agreement (BPA) call to Mdxhealth, Inc. for DX Prostate Testing services. The contract, which was awarded on April 3, 2026 with an ultimate completion date of April 2, 2027, is performed at the awardee's facility in Amarillo, Texas. This BPA call is issued under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), which streamlines the VA's procurement of specialized laboratory diagnostic services. The award carries no small business set-aside designation, indicating Mdxhealth competed as a standard commercial vendor in open market procurement. Mdxhealth, Inc., a for-profit healthcare company headquartered in Irvine, California, specializes in molecular diagnostic services for cancer testing and analysis. The company maintains an active federal contracting presence with the VA and currently holds six active Blanket Purchase Agreements across multiple VISNs, with this VISN 17 contract representing one component of the company's broader engagement in delivering advanced genomic and epigenetic prostate cancer screening capabilities to veterans nationwide. The contract supports the VA's healthcare delivery mission by providing personalized diagnostic testing services that enable tailored treatment strategies for veteran patients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 3/24/26 |